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Multidrug-resistant bacteria & methods 
for coping with resistance
Inappropriate and irrational use of antibiotics 
provides favorable conditions for selection and 
spread of antibiotic resistance. Today, the esca-
lation of multidrug-resistant (MDR) bacteria is 
documented among agents of different infec-
tious processes all over the world [1]. Resistance 
has emerged towards all classes of antibiotics 
leading to a continuous need for producing 
new drugs. However, during the past 40 years, 
a few new classes of antibiotics have been dis-
covered. One of the reasons for this decline 
is the challenges in identifying new chemical 
substances that are simultaneously effective and 
also nontoxic [2].
Constant antibiotic use leads to bacterial 
evolution to MDR forms, resulting in human 
epidemics. Examples of such MDR bacteria 
are methicillin-resistant Staphylococcus aureus 
(MRSA) and vancomycin-resistant entero-
cocci (VRE), Escherichia coli and Pseudomonas 
aeruginosa resistant to fluoroquinolones, 
Klebsiella pneumoniae resistant to ceftazidime, 
MDR Acinetobacter baumannii, and many 
other bacteria. The treatment options for these 
bacteria are increasingly limited, and  outcomes 
of  infections are significantly affected [3,4].
Results of several surveillance programs indi-
cate that a high percentage of hospital-acquired 
infections are caused by MDR strains, such as 
MRSA and VRE. A third of European countries 
had an MRSA prevalence among bloodstream-
isolated S. aureus of over 25% in 2008, accord-
ing to the study performed by the European 
Antimicrobial Resistance Surveillance System 
[5]. Furthermore, it is not only the high preva-
lence of resistance among bacteria that poses a 
threat, but also the rapid increase in levels of 
resistance. Mainous and colleagues analyzed the 
tendencies of antibiotic resistance in US hospi-
tals during a 10-year period between 1997 and 
2006. The results of the study showed a 2.5-fold 
increase in the number of infection-related 
hospitalizations with antibiotic resistance [6].
For moderate or severe infections, clinicians 
commonly initiate antibiotic therapy early and 
empirically, before the results of cultures and 
their respective antibiotic susceptibilities are 
known. The high incidence of MDR bacteria 
enhances the probability of inappropriate initial 
empirical antibiotic therapy. Many studies 
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have demonstrated the adverse impact of inappropriate initial 
antibiotic therapy on infection with increased morbidity and 
mortality [7–9].
The major routes of antibiotic resistance include enzymatic 
modification or degradation of the antibiotic molecule, alteration 
of the antibiotic target that prevents binding of the antibiotic and 
leads to loss of its activity, the efflux of antibiotics from bacterial 
cells through efflux pumps and changes in bacterial physiology 
that impact antibiotic susceptibility [2,10].
One of the promising methods in coping with bacterial resist-
ance is the use of alternative classes of antimicrobial agents and 
the application of synergistic activity between antibiotics, and 
between antibiotics and non-antibiotics [2]. Promising agents with 
antimicrobial properties are plant essential oils (EOs) and their 
constituents [11–15]. Synergistic combinations may be composed 
of antibiotics and bacteriophages [16], antibiotics and metals with 
antibacterial activities, especially nano-scaled metals [17,18], anti-
biotics with quorum-sensing inhibitors [19] and antibiotics with 
EOs of plants [20–23]. EOs have advantages both in their complex 
mechanism of action and in their complex healing properties. 
They usually possess antimicrobial activity not only against bac-
teria but also against fungi [24], protozoans [25] and viruses [26], 
which is especially important in mixed infections. Furthermore, 
EOs also have anti-inflammatory [27], immune modulatory [28], 
antioxidant [27,29] and regenerative activities [30], which make them 
promising agents in the treatment of different infections.
The purpose of this review is to summarize the studies on the 
use of plant EOs and their constituents for coping with MDR 
bacteria, and to formulate new prospects for future studies on 
this topic (Figure 1).
EOs with antibacterial properties: mechanism of action 
on bacteria
The increasing prevalence of MDR bacteria has led to renewed 
interest in natural antimicrobial substances, which were used pre-
viously but then lost their application since the introduction of 
antibiotics. The antibacterial properties of plant EOs have been 
known for many centuries. Even before the discovery of micro-
organisms, plants were accepted to be effective against infectious 
diseases [31]. Great success in the treatment of infections in the 
era of discovery of the first antibiotics diminished the role of 
natural antimicrobial products in combating bacteria. However, 
the progressive increase in the spread of antibiotic resistance gave 
new life to EOs and plant extracts.
Great interest in the antimicrobial properties of EOs nowa-
days is well illustrated by the number of PubMed publications 
on this topic. By search criteria ‘antibacterial EOs’ the authors 
found 1009 publications up to 2011. Until the 1990s, EOs were 
not studied widely, mainly because antibiotics were sufficiently 
effective against bacteria. However, the progressive increase in the 
spread of resistant bacteria has led to renewed interest in EOs: in 
the period 1991–1994 and 1995–1999, 19 and 49 articles were 
published in PubMed, respectively. Since 2000 there has been a 
rapid increase in the number of publications: reaching 134, 122 
and 111 articles in 2009, 2010 and 2011, respectively.
The chemical structure of each EO includes many compo-
nents, which have been screened for antimicrobial activity; anti-
bacterial components are derived from terpenes, such as, thymol, 
carvacrol, menthol and geraniol [15].
Among the components of EOs, oxygenated terpenes exhibit 
high antimicrobial activity compared with their hydrocarbon 
counterparts. One of the main antimicrobial components is 
thymol. Its high antibacterial activity is associated with the elec-
tron delocalization system and hydroxyl group in its structure. 
Thymol, citrals, carvacrol and p-cymene have been shown to cause 
membrane permeability by taking part in membrane swelling. 
p-cymene, via its permeabilizing activity, enables the influx of 
carvacrol into the cell thus achieving a synergistic effect when 
both components are present [32].
The high antimicrobial activity of EO components with phe-
nolic structures, such as thymol, carvacrol and eugenol, has been 
demon strated in many studies [33–36]. Several mechanisms have 
been proposed as an explanation for this. The hydroxyl group on 
eugenol might react with proteins and prevent enzyme action. 
Furthermore, hydrophobic thymol and carvacrol may dis-
turb the outer  membrane of Gram-negative bacteria releasing 
lipopolysaccharides [36].
Cinnamaldehyde is the main component of cinnamon EO, 
and has demonstrated very high antibacterial activity in many 
studies [37–39]. Cinnamaldehyde and eugenol demonstrated an 
ability to inhibit energy metabolism in Listeria monocytogenes 
and Lactobacillus sakei. This effect can be explained by interac-
tions between cinnamaldehyde and bacte-
rial cell membranes, leading to membrane 
disruption. Damage to the cell membrane 
leads to dispersion of the proton motive 
force with small ion leakage, while larger 
cell components, such as ATP, are not 
leaked. Furthermore, one of the effects of 
 cinnamaldehyde is the inhibition of glucose 
import or inhibition of glycolysis [40].
The multicomponent chemical composi-
tion and complex mechanism of action of 
EOs give them advantages over traditional 
that antibiotics possess more specific actions 
on bacterial structures. The simultaneous 
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Figure 1. Dynamics of PubMed publications on antibacterial activity of essential oils.
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effects of EO components on different bacterial sites makes it 
more difficult for the bacteria to develop resistance.
Activity of EOs & their constituents against 
MDR bacteria
In vitro activity of EOs against MDR bacteria
One of the most common examples of an MDR bacterium is 
MRSA, which was first isolated in 1961; a year after methicillin 
was introduced into clinical use [5]. Following the emergence of 
MRSA, a search for coping with this MDR bacterium also began. 
Alternative antibiotics were proposed, such as glycopeptides (van-
comycin). At the same time, the study of natural antimicrobial 
compounds for the presence of anti-MRSA activity also started. 
The first EO that demonstrated activity against MRSA was tea 
tree (Melaleuca alternifolia) oil [41]. In the 1990s, this EO was 
the most widely studied against different microorganisms [42,43]. 
The potential of tea tree oil in combating MRSA was first hypo-
thesized by Walsh and Longstaff in 1987 [44], and this topic later 
elicited wide interest among scientists. Carson et al. evaluated the 
susceptibility of 64 MRSA isolates from Australia and the UK to 
tea tree oil, among them 33 isolates were mupirocin-resistant [41]. 
The minimal inhibitory concentrations and minimal bactericidal 
concentrations were 0.25–0.313% and 0.5–0.625%, respectively, 
which indicates the susceptibility of tested strains to tea tree oil.
After 5 more years, May et al. published results of a study on 
the survival rate of MDR bacteria under exposure to tea tree oil 
at a final concentration of 5% [45]. Several bacterial strains were 
used, such as MRSA, VRE, P. aeruginosa (including gentamicin-
resistant), Stenotrophomonas maltophilia and K.  pneumoniae 
(including gentamicin-resistant); all these strains belong to MDR 
nosocomial pathogens. The authors also compared oils with dif-
ferent components: standard oil with 34.8% of terpinen-4-ol and 
5.5% of cineole and cloned (modified) oil with 43.1% of terpinen-
4-ol and 1% of cineole. All tested strains were killed within 6 h. 
In addition, modified oil with higher terpinen-4-ol and lower 
cineole content was more active than standard against all strains.
Since the 2000s, studies of the anti-MRSA activity of EOs have 
become abundant, and many EOs from different plant families 
have been shown to possess strong activity against MRSA and 
other bacterial strains (Table 1).
Extensive research was performed by Chao et al. who screened 
91 EOs and 64 blends against MRSA [46]. Of the 91 single EOs, 
78 exhibited zones of inhibition against MRSA. The highest levels 
of activity were exhibited by lemongrass, lemon myrtle, mountain 
savory, cinnamon and Melissa EOs. The authors emphasized that 
the advantage of EOs and especially of their blends is their multi-
component chemical composition that makes it more difficult 
for microorganisms to develop resistance simultaneously to all 
active components present. Moreover, the combined action of 
EO components may have synergistic effects [46]. An example of 
this synergy is the interaction between tea tree oil components 
1,8 cineole and terpinene. The effect of 1,8-cineole itself is mild, 
but in combination with terpene 1,8-cineole, it can increase the 
permeability of the bacterial membrane, thus enhancing uptake 
of terpene and contributing its activity [47].
EOs have also demonstrated significant activity against other 
MDR bacteria, such as VRE [42,48–50], A. baumannii [48,51], 
resistant strains of P. aeruginosa [52,53], E. coli [51,53], Enterobacter 
aerogenes [53], Enterobacter cloacae [51] K. pneumoniae [51,53] and 
Salmonella enterica serotype Typhimurium [53].
Data presented in Table 1 show that many studies on the anti-
MDR potential of EOs are performed in Germany, the UK 
and Turkey; however, global reports demonstrate interest in 
EOs throughout the world, in spite of the indigenous origin 
of some plants, such as tea tree. The majority of studied oils 
were produced from plants of Lamiaceae and Myrtaceae fami-
lies. Among EOs from Lamiaceae, plants the highest interest 
from researchers is elicited by lavender, mint and thyme EOs. 
Among the Myrtaceae family the most widely studied is tea 
tree oil. Regarding the methods used to assess the activity of 
EOs against MDR bacteria, published studies mainly examine 
concentration-dependent activity of EOs using the microdilution 
method, while time-dependent activity with Time–kill curves 
has not been investigated well.
Regarding mechanism of action of EOs against isolates with 
resistance to antibiotics, inhibition of the growth of MDR bacte-
ria is assumed to be caused by the same mechanisms as in sensi-
tive strains regardless of the presence of resistance to antibiotics. 
These findings support an idea about advantages of EOs owing 
to their multicomponent composition and complex mechanism 
of action [54].
Moreover, the great potential of EOs in combating antibiotic 
resistance is supported by the findings on antiplasmid activity of 
some EOs. Schelz et al. revealed rather high plasmid curing activ-
ity of peppermint oil and its major component menthol in in vitro 
experiments on the metabolic plasmid of E. coli F’lac K12 LE140 
[55]. A concentration of peppermint oil of 0.54 mg/ml caused 
37.5% plasmid elimination, while a menthol concentration of 
0.325 mg/ml has led to up to a 96% plasmid elimination.
In vitro activity of plant components against MDR 
bacteria
Only a few studies have investigated the activity of isolated plant 
components against MDR bacteria. Stermitz et al. published very 
interesting findings about the activity of 5′-methoxyhydnocarpin, 
isolated from Berberis fremontii, as an inhibitor of the NorA efflux 
pump of S. aureus [56]. This strain of S. aureus expressed efflux 
pump, which conferred resistance to quinolones and antiseptics, 
including the plant product berberine. The authors described 
complete inhibition of efflux of berberine from S. aureus, which 
is an example of synergy between the molecular components of 
a medicinal plant.
In some studies, the activity of major components was simi-
lar to the activity of the original EO, such as in the study by 
Hayes and Markovic [57], in which the activity of lemon myrtle 
(Backhousia citriodora) oil against S. aureus, E. coli, P. aeruginosa, 
Candida albicans, MRSA, Aspergillus niger, K. pneumoniae and 
Propionibacterium acnes was comparable to its major component 
citral. In other studies, the activity of the components was more 
pronounced. For example, Loughlin et al. investigated the effect of 
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Table 1. Studies demonstrating activity of essential oils from different plant families against  multidrug-
resistant bacteria (methicillin-resistant Staphylococcus aures and vancomycin-resistant enterococci).
Essential oil Major components Method for study of 
antibacterial activity
Test object including MDR 
bacteria
Country Ref.
Aristolochioideae
Aristolochia 
mollissima
2,2,7,7-tetramethyltricyclo 
[6.2.1.0(1,6)]undec-4-en-3-one (15.9 
and 13.5% from the rhizome and the 
aerial part of A. mollissima, 
respectively); (E)-β-santalol acetate 
(10.3%) and camphene (6.7%) in the 
rhizome oil; spathulenol (6.8%) in the 
oil from the aerial part
Disk diffusion, 
microdilution
20 bacterial strains, including 
MRSA, MSSA, Staphylococcus 
saprophyticus
China [82]
Cupressaceae
Juniperus 
communis
Not determined Microdilution MRSA, vancomycin-resistant 
Enterococcus faecium
UK [42]
Geraniaceae
Pelargonium 
graveolens
Not determined Vapour diffusion MRSA, VRE, Acinetobacter 
baumannii and Clostridium difficile
UK [48]
Lamiaceae
Cinnamomum 
osmophloeum
Cinnamaldehyde Microdilution Escherichia coli, Pseudomonas 
aeruginosa, Enterococcus faecalis, 
Staphylococcus aureus, 
Staphylococcus epidermidis, 
MRSA, Klebsiella pneumoniae, 
Salmonella spp., Vibrio 
parahemolyticus
Taiwan [83]
Cinnamomum 
pubescens 
Kochummen
1,6-octadien-3-ol,3,7-dimethyl 
(11.55%), cinnamaldehyde (56.15%) 
and 1-phenyl-propane-2,2-diol 
diethanoate (11.38%)
Broth microdilution MRSA, Bacillus subtilis, 
P. aeruginosa, Salmonella 
choleraesuis
Malaysia [52]
Dracocephalum 
foetidum
n-mentha-1,8-dien-10-al (39.19%), 
limonene (17%), geranial (4.56%) and 
neral (3.20%)
Microdilution B. subtilis, S. aureus, Micrococcus 
luteus, Enterococcus hirae, 
Streptococcus mutans, E. coli, 
MRSA
Republic of 
Korea
[85]
Lavandula 
angustifolia
Not determined Microdilution MRSA, vancomycin-resistant 
E. faecium
UK [42]
Lavandula 
stoechas
alpha-fenchone (41.9%), 1,8-cineole 
(15.6%), camphor (12.1%) and 
viridiflorol (4.1%) in the leaves; and 
alpha-fenchone (39.2%), myrtenyl 
acetate (9.5%), a-pinene (6.1%), 
camphor (5.9%) and 1,8-cineole 
(3.8%) in flowers
Broth microdilution MRSA Turkey [86]
Mentha piperita, 
Mentha spicata, 
Mentha arvensis
Not available Microdilution Helicobacter pylori, Salmonella 
enteritidis, E. coli, O157:H7, MRSA, 
MSSA
Japan [87]
Perilla frutescens Not determined Broth microdilution MRSA, MSSA China [88]
Salvia rosifolia a-pinene (15.7–34.8%), 1,8-cineole 
(16.6–25.1%), β-pinene (6.7–13.5%), 
β-caryophyllene (1.4–5.0%) and 
caryophyllene oxide (1.4–4.4%)
Broth microdilution MRSA, E. coli, P. aeruginosa, 
Enterobacter aerogenes, 
Salmonella enterica, serotype 
Typhimurium, S. epidermidis
Turkey [89]
MDR: Multidrug resistant; MRSA: Methicillin-resistant Staphylococcus aures; MSSA: Methicillin-susceptible S. aureus; VRE: Vancomycin-resistant enterococci.
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Table 1. Studies demonstrating activity of essential oils from different plant families against  multidrug-
resistant bacteria (methicillin-resistant Staphylococcus aures and vancomycin-resistant enterococci) (cont.).
Essential oil Major components Method for study of 
antibacterial activity
Test object including MDR 
bacteria
Country Ref.
Lamiaceae (cont.)
Satureja 
cuneifolia Ten.
Thymol (42.5–45.2%), p-cymene 
(19.4–24.3%) and carvacrol 
(8.5–13.2%)
Microdilution MRSA Turkey [90]
Satureja montana Carvacrol (45.7%), p-cymene (12.6%) 
and g-terpinene (8.1%)
Microdilution E. coli, MRSA Croatia [91]
S. cuneifolia β-cubebene (8.7%), limonene (8.3%) 
and a-pinene (6.9%)
Microdilution E. coli, MRSA Croatia [91]
Thymus vulgaris Not determined Microdilution MRSA, vancomycin-resistant 
E. faecium
UK [42]
T. vulgaris Thymol (48.1%), rho-cymene (15.6%) 
and g-terpinene (15.4%)
Disk diffusion, agar 
dilution
MRSA Iran [92]
Mentha piperita Not determined Microdilution MRSA, vancomycin-resistant 
E. faecium
UK [42]
Zataria multiflora Thymol (38.7%), carvacrol (15.3%) 
and rho-cymene (10.2%)
Broth microdilution MRSA, MSSA Iran [68]
Myrtaceae
Backhousia 
citriodora
Citral (93–98%) Microdilution 13 bacterial strains including the 
clinical strain of MRSA, 
P. aeruginosa and Clostridium 
perfringens
Australia [93]
B. citriodora Citral Microdilution MRSA, S. aureus, P. aeruginosa, 
E. coli, K. pneumoniae, 
Propionibacterium acnes
Australia [57]
Cleistocalyx 
operculatus
g-terpinene (5.76%), globulol (5.61%), 
cis-linalool oxide (5.21%), acorenol 
(5.12%) and camphene (4.12%)
Microdilution MRSA, VRE Republic of 
Korea
[84]
Eucalyptus 
citriodora Hook
Citronellal (90.07%) and citronellol 
(4.32%)
Broth microdilution MRSA Germany [94]
Eucalyptus 
globulus
Aromadendrene, 1,8-cineole and 
globulol
Broth microdilution MRSA, VRE Germany [59]
E. globulus Aromadendrene (31.17%) in fruit oil 
and 1,8-cineole (86.51%) in leaf oil
Broth microdilution MRSA Germany [94]
E. globulus Eucalyptol (47.2%), (+) spathulenol 
(18.1%) and a-pinene (9.6%)
Disk diffusion, agar 
dilution
MRSA Iran [92]
E. radiata Sieber 
ex DC
1,8-cineole (82.66%) Broth microdilution MRSA Germany [94]
Melaleuca 
alternifolia
Not determined Microdilution MRSA UK [44]
M. alternifolia Not determined Disk diffusion, 
microdilution
Clinical isolates of MRSA and 
mupirocin-resistant S. aureus
The 
Netherlands
[41]
M. alternifolia Not determined Microdilution MRSA, vancomycin-resistant 
E. faecium
UK [42]
M. alternifolia Not determined Microdilution Clinical strains of MRSA and 
coagulase-netagive staphylococci, 
reference strains of S. aureus
UK [43]
MDR: Multidrug resistant; MRSA: Methicillin-resistant Staphylococcus aures; MSSA: Methicillin-susceptible S. aureus; VRE: Vancomycin-resistant enterococci.
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terpinen-4-ol, the main component of tea tree oil, against MRSA 
and coagulase-negative staphylococci, and revealed that it had 
higher effect than tea tree oil itself [58].
Mulyaningsih et al. compared the antimicrobial properties 
of Eucalyptus globulus EO and three of its major components, 
aromadendrene, 1,8-cineole and globulol, against MRSA and 
VRE [59]. They revealed that aromadendrene was responsible for 
the activity of EO, while the effects from the other two com-
ponents was much weaker. Moreover, the authors studied the 
effect of a combination of 1,8-cineole and aromadendrene. In 
Table 1. Studies demonstrating activity of essential oils from different plant families against  multidrug-
resistant bacteria (methicillin-resistant Staphylococcus aures and vancomycin-resistant enterococci) (cont.).
Essential oil Major components Method for study of 
antibacterial activity
Test object including MDR 
bacteria
Country Ref.
Myrtaceae (cont.)
M. alternifolia Not determined Time–kill MRSA, P. aeruginosa UK [95]
M. alternifolia Not determined Time–kill Clinical strains including MRSA, 
glycopeptide-resistant enterococci, 
aminoglycoside-resistant 
klebsiellae, P. aeruginosa and 
Stenotrophomonas maltophilia
UK [45]
M. alternifolia Not determined Microdilution Clinical strains of MRSA and MSSA Japan [96]
M. alternifolia Not determined Agar dilution, 
microdilution
64 clinical strains including MRSA, 
S. aureus, E. faecalis, β-hemolytic 
streptococci, coagulase-negative 
staphylocci, P. aeruginosa, E. coli
UK [97]
M. alternifolia Not determined Microdilution 13 bacterial strains including the 
clinical strain of MRSA, P. aeruginosa 
and Clostridium perfringens
Australia [93]
M. alternifolia Not determined Microdilution, time–kill 
curves
MRSA, MSSA, coagulase-negative 
staphylococci
UK [98]
M. alternifolia Terpinen-4-ol Microdilution, time–kill 
curves
MRSA USA [99]
M. alternifolia, 
terpinen-4-ol
Terpinen-4-ol Microdilution, time–kill 
curves
Clinical strains of MRSA and 
coagulase-negative staphylococci
UK [58]
Pinaceae
Abies koreana Borneol (27.9%), a-pinene (23.2%), 
β-pinene (5.8%), terpinene-4-ol 
(3.8%), bornyl acetate (3.4%) and 
a-terpineol (3.1%)
Disk diffusion, 
microdilution
MRSA South 
Korea
[100]
Poaceae
Cymbopogon 
flexuosus
Not determined Vapour diffusion MRSA, VRE, A. baumannii and 
C. difficile
UK [48]
Rutaceae
Citrus bergamia, 
C. limon and 
C. sinensis
Not determined Microdilution, time–kill Vancomycin-resistant and 
vancomycin-sensitive E. faecalis 
and E. faecium
UK [101]
Schisandraceae
Kadsura 
longipedunculata
d-cadinene (21.79%), camphene 
(7.27%), borneol (6.05%), cubenol 
(5.12%) and d-cadinol (5.11%)
Broth microdilution MRSA, VRE, Streptococcus 
pyogenes, S. agalactiae
Germany [50]
Zingiberaceae
Etlingera elatior β-pinene (24.92%) and 1-dodecene 
(24.31%)
Broth microdilution MRSA, B. subtilis, P. aeruginosa, 
S. enterica serotype Choleraesuis
Malaysia [52]
MDR: Multidrug resistant; MRSA: Methicillin-resistant Staphylococcus aures; MSSA: Methicillin-susceptible S. aureus; VRE: Vancomycin-resistant enterococci.
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the checkerboard method, the effect in most cases was additive, 
whereas the Time–kill assay indicated synergy, which explains 
the high activity of EO.
In vivo activity of EOs against MDR bacteria
In spite of the presence of a large number of publications regarding 
the in vitro effectiveness of EOs against MDR microorganisms, 
there is a significant lack of research into their in vivo efficacy, 
either on experimental animals or in clinical application.
The majority of studies were designed to assess the effect of only 
one EO, tea tree oil, against only one MDR bacterium, MRSA. 
While in some studies the beneficial effect from tea tree oil appli-
cation was evident [60], in other studies the effect was unclear [61]. 
Sherry et al. reported treatment of chronic MRSA osteomyelitis 
with tea tree oil and eucalyptus-derived commercial formulations 
named polytoxinol [60]. Dryden et al. compared the effect of mupi-
rocin 2% nasal ointment, chlorhexidine gluconate 4% soap, silver 
sulfadiazine 1% cream versus a tea tree oil regimen, which included 
10% tea tree cream and 5% tea tree body wash, on clearance of 
MRSA carriage [61]. Mupirocin cleared 78% of nasal carriers while 
tea tree cream only cleared 47% (p = 0.0001); however, in clearing 
superficial skin sites and skin lesions, tea tree oil  treatment was 
more effective than chlorhexidine or silver sulfadiazine.
Edmondson et al. published the results of an uncontrolled, 
open-label, pilot study of effectiveness of 3% tea tree oil solution 
used for the decolonization of MRSA-positive wounds [62]. Water-
miscible tea tree oil solution was applied to 11 patients as a part of 
the wound cleansing regimen during each dressing change. The 
effect of tea tree oil application was not as pronounced as expected 
because none of the patients became MRSA negative. However, 
tea tree oil demonstrated good wound healing properties, which 
was established by the reductions in wound size after treatment.
Some studies evaluated the application of EOs for treatment of 
different infections regardless of antibiotic resistance of etiological 
agents, and these studies are also of interest because they demon-
strate general clinical effectiveness of EOs in infectious diseases. 
Natural antimicrobial compounds cannot substitute antibiotics 
in severe systemic infections. However, they can be useful in the 
treatment of skin and soft tissue, wound, gynecological, respiratory 
and other infections where local application of an antimicrobial 
agent is possible.
Orafidiya et al. demonstrated the healing properties of Ocimum 
gratissimum EO during topical application onto the wound sur-
face in experiments on rabbits [63]. Tumen et al. showed high 
wound healing and anti-inflammatory potential in EOs of 
Juniperus oxycedrus subsp. oxycedrus and J. phoenicea in experi-
mental treatment of wounds in mice by topical application of 
an ointment containing 1% EO [64]. Süntar et al. demonstrated 
remarkable wound healing capacity in an ointment containing 
olive oil extract of flowering aerial parts of Hypericum perfora-
tum L., olive oil, an equivalent mixture of Origanum majorana 
L., O.  minutiflorum Schwrd. et Davis EOs (O. aetheroleum) and 
Salvia triloba L. EOs in experimental treatment of wound in 
rats and mice [65]. A randomized double-blind clinical trial in 
60 patients with mild-to-moderate acne vulgaris demonstrated 
efficacy of topical 5% tea tree oil gel [66]. EOs may reduce the 
use of traditional antibiotics in such cases and prevent resist-
ance to them. Furthermore, they can be useful in the increase of 
activity of  traditional antibiotics by using combined therapy, as 
discussed below.
Combinations of EOs with antibiotics & other 
antimicrobial agents as a way of coping with bacterial 
resistance
Combinations of EOs with antibiotics
Potential in coping with antibiotic resistance becomes even more 
evident during combining EOs or their components with anti-
biotics. In general, combined use of antimicrobial agents opens 
a perspective in increasing antimicrobial activity and reducing 
toxicity of both agents towards human cells [67]. In spite of the 
presence of a large amount of work dedicated to either the anti-
bacterial activity of EOs, antibiotics or antibiotic–antibiotic com-
binations, there is a lack of studies on the antibacterial effect of 
combinations between EOs and antibiotics. Below we character-
ize some important studies that revealed promising interactions 
between EOs and antibiotics (Table 2).
Van Vuuren et al. studied activity of four EOs (M. alternifolia, 
Thymus vulgaris, Mentha piperita and Rosmarinus officinalis) in com-
bination with ciprofloxacin against S. aureus and K. pneumoniae 
in nine different ratios [21]. The study demonstrated the presence 
of concentration-dependent interactions between EOs and anti-
biotics: the same EO showed effect from synergistic to antagonistic 
when combined with ciprofloxacin depending on the ratios of 
both agents.
Si et al. examined combinations between O. vulgare EO and 
different antibiotics against an MDR strain of extended-spectrum 
β-lactamase-producing E. coli [22] . Most combinations were either 
synergistic or additive with no antagonistic effect.
Mahboubi and Bidgoli studied activity of Zataria  multiflora 
EO against clinical isolates of MRSA and methicillin- susceptible 
S. aureus (MSSA) and its interactions with vancomycin [68]. 
Z.  multiflora not only demonstrated high activity against both 
MSSA and MRSA with ranges of minimal inhibitory concen-
trations and minimal bactericidal concentrations of 0.25–1.00 
and 0.5–2.00 µl/ml, respectively, but also enhanced activity of 
vancomycin. Vancomycin has been commonly used for the treat-
ment of MRSA infections for 30 years; however, since appearance 
of vancomycin-intermediate S. aureus and vancomycin-resistant 
S. aureus there is a need to search for vancomycin alternatives [69]. 
Combination of EOs with  vancomycin may be one of the ways 
in prolonging its usage against MRSA.
In the study by Rosato et al. the effect of combinations between 
gentamicin and four EOs (Aniba rosaeodora, M. alternifolia, 
O. vulgare and Pelargonium graveolens) was evaluated by the 
checker board method against several reference bacterial strains 
[70]. A synergistic effect against all tested strains was observed in 
gentamicin/A. rosaeodora and gentamicin/P. graveolens combina-
tion, while in the other two combinations the effect was from syn-
ergistic to indifferent. The highest synergy was observed in com-
bination of gentamicin and P. graveolens against A. baumannii, 
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where the fractional inhibitory concentration index was 0.11. EOs 
of both A. rosaeodora and P. graveolens were characterized by high 
content of terpenalcohols – 73 and 63%, respectively. The authors 
hypothesized that just these compounds are responsible for the 
synergistic interactions with gentamicin, whose mechanism of 
action is interruption of protein synthesis by binding the 30S 
subunit of the bacteria ribosome. Likewise, terpenalcohols may 
facilitate internalization of gentamicin by interaction with bacte-
rial cellular membranes.
The purpose of the study by Fadli et al. was to find efflux pump 
inhibitors among EOs from Moroccan plants that may increase 
the activity of antibiotics against resistant isolates [53]. The EOs 
evaluated by them demonstrated activity against strains of E. coli, 
E. aerogenes, K. pneumoniae, S. enterica serotype Typhimurium 
and P. aeruginosa, which increased in the presence of efflux pump 
inhibitor PAβN. Furthermore, the results indicated that EOs of 
Thymus maroccanus and T. broussonetii at sub-inhibitory concen-
trations enhanced susceptibility of resistant strains to chloram-
phenicol. These findings support the idea regarding the presence 
of efflux pump inhibitor activity in these EOs (Figure 2) [53].
Combinations of plant constituents & antibiotics
There are only a few studies that have examined the activity of 
isolated phytoconstituents in combination with antibiotics, but 
the results of these studies are crucial in understanding the mecha-
nism of beneficial interactions. Lorenzi et al., using a microdilu-
tion method, not only demonstrated a significant reduction of 
multidrug-resistance in E. aerogenes, E. coli, P. aeruginosa and 
A. baumannii after action of Helichrysum italicum EO, but also 
found that one of the components of this EO, geraniol, signifi-
cantly increased the efficacy of β-lactams (ampicillin and penicil-
lin), quinolones (norfloxacin) and chloramphenicol [20]. Geraniol 
was revealed to be a potent efflux pump inhibitor. The results 
demonstrated that geraniol had more potent antibacterial action 
compared with PAβN in an acrAB mutant strain of E. aerogenes, 
suggesting different targets of action in these compounds, which 
should be further evaluated.
Another study on efflux pump inhibitor activity of plant com-
ponents was conducted by Smith et al., who isolated an efflux 
inhibitor ferruginol from the cones of Chamaecyparis lawsoniana 
[71]. Ferruginol inhibited activity of three resistance pumps in 
S. aureus – quinolone (NorA), tetracycline (TetK) and erythro-
mycin (MsrA). The authors observed an 80-fold increase in the 
activity of oxacillin in the presence of ferruginol, which restored 
sensitivity in the resistant strain. Efflux pump inhibitor activity 
was demonstrated in the study of ethidium bromide efflux at 
10 µM ferruginol (2.86 µg/ml) in the S. aureus strain possess-
ing the NorA efflux pump. This experiment resulted in 40% 
inhibition of ethidium bromide efflux.
Summarizing the above mentioned studies, it is worth empha-
sizing that although many EOs and their components have a high 
level of antibacterial activity [20,22,23,53,68], precautions should 
be taken when combining them with antibiotics because of the 
presence of a rather large number of antagonistic interactions [21] 
that should not be ignored [72]. These findings demonstrate the 
necessity for systematic studies of interactions between EOs and 
antibiotics to reveal undesirable combinations. Combinations of 
EOs with antibiotics should only be chosen for treatment when 
synergistic or, at least,  indifferent interactions are documented 
in vitro.
Incorporating EOs into polymeric nanoparticles
An increase in the activity of EOs can be achieved by transport-
ing them directly to the site of infection. For this purpose it 
was proposed that EOs should be incorporated into polymeric 
nano particles. This approach not only directly transports EOs to 
microbial cells, but also the small size of the particles increases 
the contact area-to-volume ratio of the antimicrobial agent and 
thus enhances its activity many times over. Interactions of EO 
components with polymeric  nanoparticles were studied by several 
researchers [73–75].
Chen et al. prepared chitosan nanoparticles grafted with either 
of two components of EOs, eugenol (phenylpropene, which is the 
component of clove, cinnamon, basil and other EOs) and carvac-
rol (monoterpenoid phenol, the component of oregano, thyme 
and other oils) [73]. Antibacterial activity of nanoparticles was 
Figure 2. Efflux pump inhibitor activity of essential oils. 
EOs inhibit efflux pumps that remove an antibiotic from the cell 
making it inactive; inhibition of efflux pumps restores the activity 
of an antibiotic.  
EO: Essential oil.  
Data taken from [20,53].
Antibiotic
EOs
Cell membrane
Efflux pump
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studied against E. coli and S. aureus. The authors demonstrated 
that the grafted eugenol and carvacrol conferred antioxidant activ-
ity to the chitosan nanoparticles. In addition, the antibacterial 
activity of these grafted nanoparticles was better or equal to the 
activity of unmodified chitosan nanoparticles. Furthermore, cyto-
toxicity of eugenol-grafted chitosan nanoparticles and carvacrol-
grafted chitosan nanoparticles in the 3T3 mouse fibroblast model 
was significantly lower than cytotoxicity of pure EOs [73].
Chitosan nanoparticles grafted with thymol of five different 
sizes (189, 167, 134, 35 and 21 nm) were synthesized by Hu 
et al. [74]. The authors revealed that thymol-loaded water-soluble 
chitosan nanoparticles had stronger antibacterial activity than 
thymol itself. In addition, with the decrease in size, these nano-
particles showed a stronger antimicrobial effect on Gram-positive 
bacteria and fungi. The minimal inhibitory concentrations of 
nanoparticles were as low as 0.00313–0.00157% (w/v) against 
S. aureus and Bacillus subtilis.
Iannitelli et al. encapsulated carvacrol into PLGA nano particles 
and studied their ability to alter the properties of preformed bac-
terial staphylococcal biofilms [75]. The hydrodynamic diameter 
of carvacrol-loaded polymeric nanoparticles was approximately 
210 nm, which allowed their diffusion through mucus layers 
of surfaces of anatomical sites. Alteration of bacterial biofilms 
was studied by using rheological tests that revealed considerable 
reduction in the elasticity and mechanical stability of biofilms. 
These changes might facilitate penetration of antimicrobial 
agents into the deep layers of bacterial biofilms.
The studies described above demonstrate that preparation of 
polymer nanoparticles grafted with EO components is beneficial 
in order to achieve an increase in antibacterial and antioxidant 
activity, reduction of toxic effects, and enhancement of bacte-
rial biofilm penetration for other antimicrobial agents. Another 
application of EOs can be their incorporation into polymeric 
nanoparticles and combinations of EOs with metallic nano-
particles; however, despite great interest shown by researchers 
towards nanoparticles as an alternative approach to antibiotic 
use, EO metallic nanoparticle combinations have not yet been 
studied.
Combinations of EOs & bacteriophages
Bacteriophages also represent a natural source of antimicrobial 
agents as an alternative approach to antibiotic treatment. Many 
studies have demonstrated great potential of bacteriophages in 
combating bacterial infections such as MDR bacteria [76–78].
Significant beneficial effects were demonstrated in the interac-
tions between bacteriophages and antibiotics [16], and between 
bacteriophages and metallic nanoparticles [79], however, there 
is a lack of studies on interactions between bacteriophages and 
EOs. One of the applications of bacteriophage–EO combina-
tions is to reduce bacterial contamination of food products. Viazis 
et al. studied survival of entero-hemorrhagic E. coli O157:H7 in 
a food model of whole baby romaine lettuce and baby spinach 
leaves after exposure to bacteriophage cocktail, BEC8, alone or 
in combination with the EO component trans-cinnamaldehyde 
(TC), depending on bacterial concentrations and temperature of 
incubation  [80]. Results of the work showed that when a low bac-
terial concentration (104 colony-forming units/ml) was exposed to 
BEC8 or TC individually at 23 or 37°C there were no survivors 
after 24 h. However, an increase of bacterial concentration to 105 
or 106 colony-forming units/ml and/or a decrease of incubation 
temperature led to a decrease in both phages and EO activities. 
By contrast, when BEC8 and TC were applied together, there 
were no survivors after 10 min at all temperature regiments and 
bacterial concentrations.
These findings indicate high mutually enhancing antibacterial 
effects of bacteriophages and EOs [80], which are worth further 
investigation with different bacterial strains and EOs. The mecha-
nism of the EO–bacteriophage combining effects on bacteria 
have not been investigated well. The most obvious is inhibition 
of bacterial growth by action on different targets in bacterial cells. 
Bacteriophages can destroy bacterial cells by two mechanisms: 
after replication (‘lysis from within’); or by adherence of a suf-
ficiently high number of phage particles to the cell and its lysis 
through alteration of the membrane electric potential, and/or the 
activity of cell wall degrading enzymes (‘lysis from without’) [81]. 
EOs may contribute to both processes: by alteration of bacterial 
cell membranes and facilitating bacteriophage entry into the cell; 
and by simultaneous action on the cell  membranes together with 
bacteriophages (Figure 3).
Expert commentary & five-year view
The wide spread of MDR bacteria causing different infectious 
processes, observed worldwide, leads to an urgent need for the 
re-assessment of methods used for coping with drug-resistance. 
Multicomponent chemical compositions and alternative mecha-
nisms of action renewed interest in the antimicrobial properties 
of natural antimicrobial compounds, such as plant EOs.
Complexity of EOs is their advantage and disadvantage 
simultaneously. Multicomponent composition gives benefit 
in overcoming bacterial resistance; however, at the same time, 
this creates problems with standardization of EOs as medical 
preparations and slows their scientific and practical implemen-
tation. For now, EOs are mainly used in folk medicine and are 
not included in standard treatment schemes of any infections. 
Identification of EO components and creation of medical prepa-
rations based on this will make it possible to broaden practical 
use of plant products.
Many EOs have demonstrated high levels of in vitro and in vivo 
activity against different types of bacteria regardless of the pres-
ence of resistance to antibiotics, including documented activ-
ity against MRSA [42,48,52,82,83], VRE [48,59,84] and other MDR 
bacteria. The mechanisms of action of EOs on MDR bacteria 
has not been well studied and are hypothesized to be the same 
as for usual antibiotic-sensitive strains: disruption of cell mem-
brane; inhibition of proton motive force with leakage of ions 
and metabolites; and inhibition of synthesis of some enzymes. 
Bacterial resistance to traditional antibiotics is caused by enzyme 
modification, changes in binding sites or targets of action, efflux 
of the antibiotic from the bacterium or changes in the metabolic 
activity of the bacterial cell. In turn, activity of EOs against MDR 
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bacteria can be explained by simultaneous action on different 
targets; and this action does not depend on target modifications 
leading to antibiotic ineffectiveness. Some EOs demonstrated 
antiplasmid activity, which has great potential in  coping with 
 bacterial resistance and merits further detailed investigation.
Furthermore, EOs not only demonstrated activity against 
MDR bacteria themselves, but also showed potential for the 
development of synergistic combinations that increases the anti-
bacterial effect of antibiotics. EOs may alter the antibiotic efflux 
pumps and this helps to restore the activity of antibiotics that are 
losing their clinical application, or to prolong the use of pres-
ently effective antibiotics. However, it is worth mentioning that 
despite high activity of EOs and antibiotics, some EO–antibiotic 
combinations showed antagonistic effects, the mechanisms of 
which are not understood and need further study.
Bacteriophages are thought to be another alternative to 
anti biotic treatment, and some combinations between bacte-
riophages and EOs have also shown promising activity against 
bacteria [80]. However, such studies devoted to antibacterial 
potential of bacteriophage-EO combinations are very scarce; 
the mechanisms of these interactions are poorly understood. 
Understanding the potential of interactions between bacterio-
phages and EOs in combating bacterial resistance, their dose- 
and time-dependent effects along with a deeper understanding 
of the mechanism of combined action can be planned for the 
next 5 years.
Further research should also be performed during the next 
5 years in order to better understand the mechanisms of action 
of EOs against MDR bacteria, especially those that have 
recently emerged, such as vancomycin-intermediate S. aureus 
and vancomycin-resistant S. aureus, through better investiga-
tion of antiplasmid activity of EOs and the mechanisms of EO 
interactions with antibiotics, and the resultant production of 
clinically applicable forms of such combined drugs.
In summary, the antibacterial application of EOs is not a new 
topic, but ineffectiveness of traditional antibiotics puts a new 
focus on this area, and the presence of many advantages in EOs, 
both in the mechanisms of action and complex healing proper-
ties, makes them promising agents in coping with MDR bacteria 
either alone or as a support for traditional antibiotic treatment.
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Key issues
• The high prevalence of multidrug-resistant (MDR) bacteria has increased interest in alternative methods of antibacterial treatment; 
among them, the use of essential oils (EOs) and their constituents with antimicrobial properties elicits wide interest.
• EOs have a multicomponent chemical composition and alternative mechanisms of action, including the ability to affect many bacterial 
structures simultaneously, which enables their activity both against antibiotic-sensitive and antibiotic-resistant isolates. Antiplasmid 
activity of EOs has great potential in combating MDR bacteria and in restricting their distribution.
• Different combinations of EOs and traditional antibiotics demonstrated an enhancing effect, which is important in restoring activity of 
inactive antibiotics and prolonging the activity of presently highly efficient drugs. One of the explanations for the beneficial interactions 
between antibiotics and EOs is the efflux pump inhibitor activity of EOs.
• Studies have shown that components of EOs can be successfully incorporated into polymeric nanoparticles; this not only increases their 
activity but also reduces possible toxic effects of EOs and allows the possibility for direct delivery of EOs into the site of infection.
• Combinations of bacteriophages and EOs have demonstrated promising beneficial effects and represent another alternative to 
antibiotic treatment that merits further investigation.
• Future studies should also be directed towards better understanding the mechanism of action of EOs against MDR bacteria and to the 
development of pharmaceutical formulations appropriate for the treatment of local and systemic infections.
Figure 3. Possible mechanisms of antibacterial action of 
essential oils alone and in combination with 
bacteriophages. Mechansims of action may include (A) 
disintegration of cytoplasmic membrane and interaction with 
membrane proteins (ATPases and others), (B) disturbance of the 
outer membrane of Gram-negative bacteria with the release of 
lipopolysaccharides, (C) destabilization of the proton motive force 
with leakage of ions, (D) coagulation of the cell content, 
(E) inhibition of enzyme synthesis, and (F) damage to bacterial cell 
membrane caused by EOs, which either facilitates penetration of 
bacteriophages with subsequent replication inside the bacterial cell 
and its lysis, or is supported by simultaneous action of 
bacteriophages and EOs on the cell membranes.  
BF: Bacteriophage; EO: Essential oil.  
Data taken from [81,102]
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